These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3027765

  • 41. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
    Robberecht P, De Neef P, Gourlet P, Cauvin A, Coy DH, Christophe J.
    Regul Pept; 1989; 26(2):117-26. PubMed ID: 2552509
    [Abstract] [Full Text] [Related]

  • 42. Comparison of VIP-secretin receptors in rat and human lung.
    Christophe J, Chatelain P, Taton G, Delhaye M, Waelbroeck M, Robberecht P.
    Peptides; 1981; 2 Suppl 2():253-8. PubMed ID: 6123988
    [Abstract] [Full Text] [Related]

  • 43. A novel vasoactive intestinal peptide (VIP) from elasmobranch intestine has full affinity for mammalian pancreatic VIP receptors.
    Dimaline R, Young J, Thwaites DT, Lee CM, Shuttleworth TJ, Thorndyke MC.
    Biochim Biophys Acta; 1987 Aug 19; 930(1):97-100. PubMed ID: 2441759
    [Abstract] [Full Text] [Related]

  • 44. The preparation of biotinyl-epsilon-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor.
    Andersson M, Marie JC, Carlquist M, Mutt V.
    FEBS Lett; 1991 Apr 22; 282(1):35-40. PubMed ID: 1851109
    [Abstract] [Full Text] [Related]

  • 45. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S, Rattan S.
    J Pharmacol Exp Ther; 1993 Jul 22; 266(1):392-9. PubMed ID: 8392560
    [Abstract] [Full Text] [Related]

  • 46. Vasoactive intestinal peptide and its receptors in fetuses with cystic fibrosis.
    Chastre E, Bawab W, Faure C, Emami S, Muller F, Boué A, Gespach C.
    Am J Physiol; 1989 Oct 22; 257(4 Pt 1):G561-9. PubMed ID: 2552825
    [Abstract] [Full Text] [Related]

  • 47. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
    Couvineau A, Gammeltoft S, Laburthe M.
    J Neurochem; 1986 Nov 22; 47(5):1469-75. PubMed ID: 3020175
    [Abstract] [Full Text] [Related]

  • 48. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.
    O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM.
    Regul Pept; 1992 Feb 18; 37(3):213-26. PubMed ID: 1313595
    [Abstract] [Full Text] [Related]

  • 49. Neuronal VIP in salivary glands: distribution and release.
    Uddman R, Fahrenkrug J, Malm L, Alumets J, Håkanson R, Sundler F.
    Acta Physiol Scand; 1980 Sep 18; 110(1):31-8. PubMed ID: 6258394
    [Abstract] [Full Text] [Related]

  • 50. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
    Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers A, Vandermeers-Piret MC, Robberecht P, Christophe J.
    Biochim Biophys Acta; 1991 Jul 22; 1066(2):245-51. PubMed ID: 1649637
    [Abstract] [Full Text] [Related]

  • 51. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
    Huang M, Rorstad OP.
    J Neurochem; 1984 Sep 22; 43(3):849-56. PubMed ID: 6086840
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences.
    Couvineau A, Rouyer-Fessard C, Fournier A, St Pierre S, Pipkorn R, Laburthe M.
    Biochem Biophys Res Commun; 1984 Jun 15; 121(2):493-8. PubMed ID: 6329205
    [Abstract] [Full Text] [Related]

  • 55. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
    Gourlet P, Vertongen P, Vandermeers A, Vandermeers-Piret MC, Rathe J, De Neef P, Waelbroeck M, Robberecht P.
    Peptides; 1997 Jun 15; 18(3):403-8. PubMed ID: 9145428
    [Abstract] [Full Text] [Related]

  • 56. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase.
    Besson J, Malassiné A, Ferré F.
    Regul Pept; 1987 Nov 15; 19(3-4):197-207. PubMed ID: 2829291
    [Abstract] [Full Text] [Related]

  • 57. Coupling of receptors in brain membranes by fusion to the adenylate cyclase system of a foreign effector cell.
    Olasmaa M, Terenius L.
    Brain Res; 1988 Nov 08; 473(1):29-36. PubMed ID: 2850088
    [Abstract] [Full Text] [Related]

  • 58. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE, Wood CL, O'Dorisio MS, Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1987 Mar 08; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.